Dfmo: Clinical Trials

1 trial of Dfmo, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Unknown 1

Follow Dfmo: new trials by email Literature Review of Dfmo trials Research Report on Dfmo

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients
Eflornithine, Lomustine - Anaplastic Astrocytoma, Recurrent Anaplastic Astrocytoma
Phase 3UnknownOrbus Therapeutics, Inc.3432016-07-012022-01-21

Conditions studied

Astrocytoma (1)  ·  Brain Neoplasms (1)  ·  Glioma (1)

Sponsors

Orbus Therapeutics, Inc. (1)

Countries

Belgium (1)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Netherlands (1)  ·  United Kingdom (1)  ·  United States (1)

Results publications

PMID 41325560